Carson Wealth (CWM LLC)
IBB icon

Carson Wealth (CWM LLC)’s iShares Biotechnology ETF IBB Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Buy
6,194
+20
+0.3% +$3.42K ﹤0.01% 1512
2025
Q4 		$1.04M Sell
6,174
-209
-3% -$33.9K ﹤0.01% 1476
2025
Q3 		$921K Sell
6,383
-138
-2% -$18.8K ﹤0.01% 1460
2025
Q2 		$825K Sell
6,521
-1,371
-17% -$168K ﹤0.01% 1347
2025
Q1 		$1.01M Buy
7,892
+14
+0.2% +$1.9K ﹤0.01% 1121
2024
Q4 		$1.04M Buy
7,878
+150
+2% +$21.1K ﹤0.01% 1060
2024
Q3 		$1.13M Sell
7,728
-107
-1% -$15.5K ﹤0.01% 958
2024
Q2 		$1.07M Buy
7,835
+99
+1% +$13.2K 0.01% 851
2024
Q1 		$1.06M Sell
7,736
-733
-9% -$100K 0.01% 824
2023
Q4 		$1.15M Sell
8,469
-458
-5% -$55.9K 0.01% 748
2023
Q3 		$1.09M Buy
8,927
+183
+2% +$23.3K 0.01% 708
2023
Q2 		$1.11M Buy
8,744
+329
+4% +$42.7K 0.01% 682
2023
Q1 		$1.09M Buy
8,415
+491
+6% +$64.3K 0.01% 643
2022
Q4 		$1.04M Buy
7,924
+601
+8% +$77.7K 0.01% 603
2022
Q3 		$856K Sell
7,323
-1,223
-14% -$152K 0.01% 595
2022
Q2 		$1M Sell
8,546
-251
-3% -$29.8K 0.01% 564
2022
Q1 		$1.15M Sell
8,797
-1,116
-11% -$145K 0.01% 532
2021
Q4 		$1.51M Buy
+9,913
New +$1.53M 0.01% 492
2021
Q2 		$1.51M Hold
9,224
– – 0.01% 497
2021
Q1 		$1.51M Hold
9,224
– – 0.01% 497
2020
Q4 		$1.51M Hold
9,224
– – 0.01% 497
2020
Q3 		$1.51M Hold
9,224
– – 0.01% 497
2020
Q2 		$1.51M Hold
9,224
– – 0.01% 497
2020
Q1 		$1.51M Hold
9,224
– – 0.01% 497
2019
Q4 		$1.51M Hold
9,224
– – 0.01% 497
2019
Q3 		$1.51M Hold
9,224
– – 0.01% 497
2019
Q2 		$1.51M Hold
9,224
– – 0.01% 497
2019
Q1 		$1.51M Buy
9,224
+2,638
+40% +$289K 0.01% 497
2018
Q4 		$635K Sell
6,586
-2,176
-25% -$231K 0.02% 420
2018
Q3 		$1.07M Buy
8,762
+6,723
+330% +$792K 0.03% 314
2018
Q2 		$224K Sell
2,039
-91
-4% -$9.73K 0.01% 407
2018
Q1 		$227K Buy
2,130
+216
+11% +$23.9K 0.01% 352
2017
Q4 		$204K Buy
1,914
+531
+38% +$56.8K 0.01% 341
2017
Q3 		$154K Buy
1,383
+531
+62% +$56.8K 0.01% 357
2017
Q2 		$88K Sell
852
-243
-22% -$23.9K ﹤0.01% 398
2017
Q1 		$107K Buy
1,095
+15
+1% +$1.44K 0.01% 359
2016
Q4 		$96K Sell
1,080
-420
-28% -$38.2K 0.01% 352
2016
Q3 		$145K Buy
1,500
+51
+4% +$4.85K 0.01% 293
2016
Q2 		$124K Buy
1,449
+420
+41% +$37.7K 0.01% 283
2016
Q1 		$89K Buy
1,029
+501
+95% +$44.8K 0.01% 289
2015
Q4 		$60K Buy
528
+207
+64% +$22.5K 0.01% 302
2015
Q3 		$32K Buy
+321
New +$38.5K ﹤0.01% 322
2014
Q1 		– Sell
-300
Closed -$23K – 305
2013
Q4 		$23K Hold
300
– – ﹤0.01% 356
2013
Q3 		$21K Buy
+300
New +$19.7K 0.01% 265

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Carson Wealth (CWM LLC)'s IBB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its iShares Biotechnology ETF (IBB) stake by 0.32% in Q1 2026, buying an estimated $3.42K and bringing the position to 6,194 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

Carson Wealth (CWM LLC) first reported a position in IBB in Q3 2013 and has held it in 44 quarters since. The position peaked at $1.51M in Q4 2021. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 6,194 shares of iShares Biotechnology ETF worth $1.05M as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 20 iShares Biotechnology ETF shares in Q1 2026, an estimated $3.42K.
  • iShares Biotechnology ETF made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1512 holding.
  • Carson Wealth (CWM LLC) first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 44 quarters since.
  • Carson Wealth (CWM LLC)'s iShares Biotechnology ETF position peaked at $1.51M in Q4 2021.
  • 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.